Page 156 - Haematologica May 2020

B. Depreter et al.
35. Gentles AJ, Plevritis SK, Majeti R, et al.
Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA. 2010;304(24):2706-2715.
36. Saito Y, Kitamura H, Hijikata A, et al. Identification of therapeutic targets for qui- escent, chemotherapy-resistant human leukemia stem cells. Sci Transl Med. 2010;2(17):17ra9.
37. de Leeuw DC, Denkers F, Olthof MC, et al. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. Cancer Res. 2014;74(7):2094- 2105.
38. Hellemans J, Mortier G, De Paepe A, et al. qBase relative quantification framework and software for management and auto- mated analysis of real-time quantitative PCR data. Genome Biol. 2007;8(2):R19.
39. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quanti- tative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):Research0034.
40. van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lympho- proliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17(12):2257-2317.
41. Essand M, Vasmatzis G, Brinkmann U, et al. High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate. Proc Natl Acad Sci U S A. 1999;96(16):9287-9292.
42. Wolfgang CD, Essand M, Vincent JJ, Lee B, Pastan I. TARP: A nuclear protein expressed in prostate and breast cancer cells derived from an alternate reading frame of the T cell receptor gamma chain locus. Proc Natl Acad Sci U S A. 2000;97(17):9437-9442.
43. Maeda H, Nagata S, Wolfgang CD, et al. The T cell receptor gamma chain alternate reading frame protein (TARP), a prostate- specific protein localized in mitochondria. J
Biol Chem. 2004;279(23):24561-24568.
44. Qi C, Jia X, Lu L, et al. HEK293T Cells Are Heterozygous for CCR5 Delta 32
Mutation. PloS One. 2016;11(4):e0152975. 45. Lefranc MP, Forster A, Rabbitts TH. Genetic polymorphism and exon changes of the constant regions of the human T-cell rearranging gene gamma. Proc Natl Acad
Sci U S A. 1986;83(24):9596-9600.
46. Carlsson B, Totterman TH, Essand M. Generation of cytotoxic T lymphocytes specific for the prostate and breast tissue antigen TARP. Prostate. 2004;61(2):161-170.
duplication (FLT3-ITD) is recognized by leukemia-reactive autologous CD8+ T cells. Blood. 2007;109(7):2985-2988.
54. Quek L, Otto GW, Garnett C, et al. Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage. J Exp Med. 2016;213(8):1513-1535.
55. Fritzsche FR, Stephan C, Gerhardt J, et al. Diagnostic and prognostic value of T-cell receptor gamma alternative reading frame protein (TARP) expression in prostate can- cer. Histol Histopathol. 2010;25(6):733-
47. Hillerdal V, Nilsson B, Carlsson B, et al. T 739.
cells engineered with a T cell receptor against the prostate antigen TARP specifi- cally kill HLA-A2+ prostate and breast can- cer cells. Proc Natl Acad Sci U S A. 2012; 109(39):15877-15881.
48. Wolfgang CD, Essand M, Lee B, et al. T-cell receptor gamma chain alternate reading frame protein (TARP) expression in prostate cancer cells leads to an increased growth rate and induction of caveolins and amphiregulin. Cancer Res. 2001; 61(22):8122-8126.
49. Yue H, Cai Y, Song Y, et al. Elevated TARP promotes proliferation and metastasis of salivary adenoid cystic carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol. 2017;123(4):468-476.
50. Farrar JE, Schuback HL, Ries RE, et al. Genomic profiling of pediatric acute myeloid leukemia reveals a changing muta- tional landscape from disease diagnosis to relapse. Cancer Res. 2016;76(8):2197-2205.
51. Bolouri H, Farrar JE, Triche T, et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent struc- tural alterations and age-specific mutation- al interactions. Nat Med. 2017;24(1):103- 112.
52. Lamba JK, Cao X, Raimondi SC, et al. Integrated epigenetic and genetic analysis identifies markers of prognostic signifi- cance in pediatric acute myeloid leukemia. Oncotarget. 2018;9(42):26711-26723.
53. Graf C, Heidel F, Tenzer S, et al. A neoepi- tope generated by an FLT3 internal tandem
56. van Buul JD, Voermans C, van Gelderen J, et al. Leukocyte-endothelium interaction promotes SDF-1-dependent polarization of CXCR4. J Biol Chem. 2003;278(32):30302- 30310.
57. Salgia R, Li JL, Ewaniuk DS, et al. BCR/ABL induces multiple abnormalities of cytoskeletal function. J Clin Invest. 1997; 100(1):46-57.
58. Boyd AL, Campbell CJV, Hopkins CI, et al. Niche displacement of human leukemic stem cells uniquely allows their competi- tive replacement with healthy HSPCs. J Exp Med. 2014;211(10):1925-1935.
59. Oh S, Terabe M, Pendleton CD, et al. Human CTLs to wild-type and enhanced epitopes of a novel prostate and breast tumor-associated protein, TARP, lyse human breast cancer cells. Cancer Res. 2004;64(7):2610-2618.
60. Coulie PG, Van den Eynde BJ, van der Bruggen P, et al. Tumour antigens recog- nized by T lymphocytes: at the core of can- cer immunotherapy. Nat Rev Cancer. 2014; 14(2):135-146.
61. Hillerdal V, Boura VF, Bjorkelund H, et al. Avidity characterization of genetically engi- neered T-cells with novel and established approaches. BMC Immunol. 2016;17(1):23.
62. Heemskerk MH, Hagedoorn RS, van der Hoorn MA, et al. Efficiency of T-cell recep- tor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood. 2007;109(1):235-243.
1316
haematologica | 2020; 105(5)